Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: AIDS Behav. 2016 Apr;20(4):699–709. doi: 10.1007/s10461-015-1142-7

Table 3.

Logistic regression model of ‘amplified HIV transmission risk’

Characteristics Level Bivariate model Multivariable modela


OR (95 % CI) p OR (95 % CI) p
Site Brazil vs. Thailand 2.80 (1.84, 4.25) <0.0001 2.44 (1.56, 3.83) .0001
Risk group Heterosexual women vs. heterosexual men 1.67 (0.94, 2.96) .0782 1.50 (0.83, 2.74) .1828
MSM vs. heterosexual men 3.26 (1.89, 5.63) <0.0001 2.89 (1.65, 5.07) .0002
Substance use No vs. yes 0.60 (0.34, 1.04) .0702 0.86 (0.46, 1.60) .6323
CESD Mild to moderate depression vs. no depression 0.92 (0.55, 1.54) .7586
Severe depression vs. no depression 1.42 (0.87, 2.32) .1659
ART adherence Excellent vs. very poor 0.59 (0.09, 3.84) .5841
Very good vs. very poor 0.35 (0.06, 2.23) .2688
Good vs. very poor 0.50 (0.08, 3.14) .4636
Fair vs. very poor 0.75 (0.11, 4.92) .7644
Poor vs. very poor 1.50 (0.14, 16.54) .7406
ACTG SF-21 scales
General health General health 1.00 (0.99, 1.01) .5030
Physical functioning Physical functioning 0.99 (0.98, 1.00) .1320
Role functioning Role functioning 0.99 (0.99, 1.00) .2321
Social functioning Social functioning 1.00 (0.99, 1.01) .6076
Cognitive functioning Cognitive functioning 0.99 (0.98, 1.00) .1504
Pain Pain 1.00 (0.99, 1.01) .9297
Mental health Mental health 1.00 (0.98, 1.01) .5761
Energy/fatigue Energy/fatigue 1.00 (0.99, 1.01) .4415
Social support Social support 0.99 (0.95, 1.02) .3948
HIV disclosure Factor 1 (disclosure) 0.77 (0.47, 1.25) .2874
Factor 2 (fear of consequences of disclosure) 1.81 (1.22, 2.67) .0029 1.39 (0.92, 2.08) .1159
Alcohol score AUDIT score 1.01 (0.98, 1.04) .5319

Amplified HIV transmission risk was defined as detectable viral load OR STI and engaged in condomless anal or vaginal sex with an HIV-uninfected or unknown status partner in past three months. Not being in this amplified HIV transmission risk category was defined as suppressed viral load and no STI or no condomless insertive or penetrative sex with an HIV-uninfected or unknown status partner in the past 3 months. This analysis only includes individuals where HIV RNA data were available (from Thailand and Brazil) and STI lab test results (n = 457)

a

Covariates with p < .1 were included in the multivariable model